A phosphotyrosyl mimetic peptide reverses impairment of insulin- stimulated translocation of GLUT4 caused by overexpression of PTP1B in rat adipose cells

Hui Chen, Li Na Cong, Yunhua Li, Zhu Jun Yao, Li Wu, Zhong-Yin Zhang, Terrence R. Burke, Michael J. Quon

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Biological actions of insulin are initiated by activation of the insulin receptor tyrosine kinase. Protein tyrosine phosphatases (PTPases) PTP1B and PTPα are known to dephosphorylate the insulin receptor and may contribute to insulin resistance in diseases such as diabetes. We previously reported that overexpression of PTP1B in rat adipose cells significantly impairs insulin- stimulated translocation of GLUT4 [Chen, H., et al. (1997) J. Biol. Chem. 272, 8026]. In the present study, we treated adipose cells with a PTPase inhibitor containing the phosphotyrosyl mimetic difluorophosphonomethyl phenylalanine (F2Pmp) to determine whether we could improve the insulin resistance caused by overexpression of PTP1B or PTPα. Rat adipose cells transfected by electroporation with either PTP1B or PTPα were treated without or with the inhibitor, and effects on insulin-stimulated translocation of a cotransfected epitope-tagged GLUT4 were studied. The IC50 of the F2Pmp-containing inhibitor is 180 nM for PTP1B and 10 mM for PTPα in vitro. As expected, in the absence of the inhibitor, overexpression of either PTP1B or PTPα caused a significant decrease in the amount of GLUT4 at the cell surface both in the absence and in the presence of insulin when compared with control cells transfected with epitope-tagged GLUT4 alone. Interestingly, the insulin resistance caused by overexpression of PTP1B (but not PTPα) was reversed by treating the transfected cells with the F2Pmp- containing inhibitor. Furthermore, the inhibitor blocked the insulin- stimulated association of PTP1B with the insulin receptor. We conclude that the F2Pmp-containing compound is a potent and specific inhibitor of overexpressed PTP1B that may be useful for designing rational therapies for treating insulin resistant diseases such as diabetes.

Original languageEnglish (US)
Pages (from-to)384-389
Number of pages6
JournalBiochemistry
Volume38
Issue number1
DOIs
StatePublished - Jan 5 1999
Externally publishedYes

Fingerprint

Rats
Insulin
Peptides
Insulin Resistance
Protein Tyrosine Phosphatases
Insulin Receptor
Epitopes
Medical problems
Electroporation
Phenylalanine
Inhibitory Concentration 50
Chemical activation
Association reactions
Therapeutics

ASJC Scopus subject areas

  • Biochemistry

Cite this

A phosphotyrosyl mimetic peptide reverses impairment of insulin- stimulated translocation of GLUT4 caused by overexpression of PTP1B in rat adipose cells. / Chen, Hui; Cong, Li Na; Li, Yunhua; Yao, Zhu Jun; Wu, Li; Zhang, Zhong-Yin; Burke, Terrence R.; Quon, Michael J.

In: Biochemistry, Vol. 38, No. 1, 05.01.1999, p. 384-389.

Research output: Contribution to journalArticle

Chen, Hui ; Cong, Li Na ; Li, Yunhua ; Yao, Zhu Jun ; Wu, Li ; Zhang, Zhong-Yin ; Burke, Terrence R. ; Quon, Michael J. / A phosphotyrosyl mimetic peptide reverses impairment of insulin- stimulated translocation of GLUT4 caused by overexpression of PTP1B in rat adipose cells. In: Biochemistry. 1999 ; Vol. 38, No. 1. pp. 384-389.
@article{bb85ec8d7e57426c879b68d9bd598b06,
title = "A phosphotyrosyl mimetic peptide reverses impairment of insulin- stimulated translocation of GLUT4 caused by overexpression of PTP1B in rat adipose cells",
abstract = "Biological actions of insulin are initiated by activation of the insulin receptor tyrosine kinase. Protein tyrosine phosphatases (PTPases) PTP1B and PTPα are known to dephosphorylate the insulin receptor and may contribute to insulin resistance in diseases such as diabetes. We previously reported that overexpression of PTP1B in rat adipose cells significantly impairs insulin- stimulated translocation of GLUT4 [Chen, H., et al. (1997) J. Biol. Chem. 272, 8026]. In the present study, we treated adipose cells with a PTPase inhibitor containing the phosphotyrosyl mimetic difluorophosphonomethyl phenylalanine (F2Pmp) to determine whether we could improve the insulin resistance caused by overexpression of PTP1B or PTPα. Rat adipose cells transfected by electroporation with either PTP1B or PTPα were treated without or with the inhibitor, and effects on insulin-stimulated translocation of a cotransfected epitope-tagged GLUT4 were studied. The IC50 of the F2Pmp-containing inhibitor is 180 nM for PTP1B and 10 mM for PTPα in vitro. As expected, in the absence of the inhibitor, overexpression of either PTP1B or PTPα caused a significant decrease in the amount of GLUT4 at the cell surface both in the absence and in the presence of insulin when compared with control cells transfected with epitope-tagged GLUT4 alone. Interestingly, the insulin resistance caused by overexpression of PTP1B (but not PTPα) was reversed by treating the transfected cells with the F2Pmp- containing inhibitor. Furthermore, the inhibitor blocked the insulin- stimulated association of PTP1B with the insulin receptor. We conclude that the F2Pmp-containing compound is a potent and specific inhibitor of overexpressed PTP1B that may be useful for designing rational therapies for treating insulin resistant diseases such as diabetes.",
author = "Hui Chen and Cong, {Li Na} and Yunhua Li and Yao, {Zhu Jun} and Li Wu and Zhong-Yin Zhang and Burke, {Terrence R.} and Quon, {Michael J.}",
year = "1999",
month = "1",
day = "5",
doi = "10.1021/bi9816103",
language = "English (US)",
volume = "38",
pages = "384--389",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "1",

}

TY - JOUR

T1 - A phosphotyrosyl mimetic peptide reverses impairment of insulin- stimulated translocation of GLUT4 caused by overexpression of PTP1B in rat adipose cells

AU - Chen, Hui

AU - Cong, Li Na

AU - Li, Yunhua

AU - Yao, Zhu Jun

AU - Wu, Li

AU - Zhang, Zhong-Yin

AU - Burke, Terrence R.

AU - Quon, Michael J.

PY - 1999/1/5

Y1 - 1999/1/5

N2 - Biological actions of insulin are initiated by activation of the insulin receptor tyrosine kinase. Protein tyrosine phosphatases (PTPases) PTP1B and PTPα are known to dephosphorylate the insulin receptor and may contribute to insulin resistance in diseases such as diabetes. We previously reported that overexpression of PTP1B in rat adipose cells significantly impairs insulin- stimulated translocation of GLUT4 [Chen, H., et al. (1997) J. Biol. Chem. 272, 8026]. In the present study, we treated adipose cells with a PTPase inhibitor containing the phosphotyrosyl mimetic difluorophosphonomethyl phenylalanine (F2Pmp) to determine whether we could improve the insulin resistance caused by overexpression of PTP1B or PTPα. Rat adipose cells transfected by electroporation with either PTP1B or PTPα were treated without or with the inhibitor, and effects on insulin-stimulated translocation of a cotransfected epitope-tagged GLUT4 were studied. The IC50 of the F2Pmp-containing inhibitor is 180 nM for PTP1B and 10 mM for PTPα in vitro. As expected, in the absence of the inhibitor, overexpression of either PTP1B or PTPα caused a significant decrease in the amount of GLUT4 at the cell surface both in the absence and in the presence of insulin when compared with control cells transfected with epitope-tagged GLUT4 alone. Interestingly, the insulin resistance caused by overexpression of PTP1B (but not PTPα) was reversed by treating the transfected cells with the F2Pmp- containing inhibitor. Furthermore, the inhibitor blocked the insulin- stimulated association of PTP1B with the insulin receptor. We conclude that the F2Pmp-containing compound is a potent and specific inhibitor of overexpressed PTP1B that may be useful for designing rational therapies for treating insulin resistant diseases such as diabetes.

AB - Biological actions of insulin are initiated by activation of the insulin receptor tyrosine kinase. Protein tyrosine phosphatases (PTPases) PTP1B and PTPα are known to dephosphorylate the insulin receptor and may contribute to insulin resistance in diseases such as diabetes. We previously reported that overexpression of PTP1B in rat adipose cells significantly impairs insulin- stimulated translocation of GLUT4 [Chen, H., et al. (1997) J. Biol. Chem. 272, 8026]. In the present study, we treated adipose cells with a PTPase inhibitor containing the phosphotyrosyl mimetic difluorophosphonomethyl phenylalanine (F2Pmp) to determine whether we could improve the insulin resistance caused by overexpression of PTP1B or PTPα. Rat adipose cells transfected by electroporation with either PTP1B or PTPα were treated without or with the inhibitor, and effects on insulin-stimulated translocation of a cotransfected epitope-tagged GLUT4 were studied. The IC50 of the F2Pmp-containing inhibitor is 180 nM for PTP1B and 10 mM for PTPα in vitro. As expected, in the absence of the inhibitor, overexpression of either PTP1B or PTPα caused a significant decrease in the amount of GLUT4 at the cell surface both in the absence and in the presence of insulin when compared with control cells transfected with epitope-tagged GLUT4 alone. Interestingly, the insulin resistance caused by overexpression of PTP1B (but not PTPα) was reversed by treating the transfected cells with the F2Pmp- containing inhibitor. Furthermore, the inhibitor blocked the insulin- stimulated association of PTP1B with the insulin receptor. We conclude that the F2Pmp-containing compound is a potent and specific inhibitor of overexpressed PTP1B that may be useful for designing rational therapies for treating insulin resistant diseases such as diabetes.

UR - http://www.scopus.com/inward/record.url?scp=0033524450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033524450&partnerID=8YFLogxK

U2 - 10.1021/bi9816103

DO - 10.1021/bi9816103

M3 - Article

VL - 38

SP - 384

EP - 389

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 1

ER -